If you have been reading about heptapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-03. Numbers and descriptions here follow the published literature rather than marketing material.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Development took place at the Institute of Molecular Genetics of the Russian Academy of Sciences, where a series of short peptides were designed in the 1980s and 1990s. Selank was selected from variants of tuftsin that showed resistance to plasma peptidases. Russian regulatory approval covers it as an anxiolytic agent given intranasally. Outside that market the compound is normally handled as a research chemical rather than a medicine, and no widely recognised international pharmacopoeial monograph exists. The name Selank is a coined trade designation rather than a systematic chemical name.
Enzymatic stability motivates the extra three residues at the carboxyl end. Native tuftsin is cleaved quickly by circulating aminopeptidases and carboxypeptidases, which limits its duration of action and its usefulness as a tool compound. Extending the chain with proline-rich segments is a common design tactic because proline constrains the backbone and slows proteolysis. The same Pro-Gly-Pro motif appears in other Russian-developed peptides of the era. Whether the full seven-residue chain is required for activity, or whether it acts mainly as a prodrug releasing tuftsin, remains unresolved.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Free peptide form |
| Molecular mass | About 751.9 Da | Calculated average mass |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Single-letter form TKPRPGP |
| Structural basis | Tuftsin analogue | Extended version of a natural tetrapeptide |
| Development origin | Russian Academy of Sciences | Work carried out from the 1980s onward |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
Most published work on selank originates from a small number of research groups in the Russian Federation. A large share of that record appears in Russian-language journals, which limits access for readers who rely on English-indexed databases. Independent replication by laboratories outside the original research network is sparse in publicly available sources. This concentration of origin and language is a frequently noted feature when the compound is summarized in broader reviews of synthetic peptides.
Reported pharmacological effects center on reduced anxiety-like behavior in animal models and on measures of memory and learning. Proposed contributing mechanisms include modulation of GABAergic signaling, shifts in monoamine turnover, and changes in the activity of enzymes that degrade neuropeptides. Effects on the expression of genes linked to neuroplasticity have also been described. No single molecular target is widely accepted, and whether the behavioral findings arise from one pathway or several remains an open question.
The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
== Research Applications == The territorial matrix is studied in various fields, such as tissue engineering, regenerative medicine, and biomaterials. Techniques such as immunofluorescence and atomic force microscopy (AFM) are commonly used for visualization. These methods are used to measure the stiffness, elasticity, and composition of the matrix at a nano- and micro-scale resolution. More importantly, information may be gleaned from these visualization methods about various pathologies of cartilage and its components. In regenerative medicine, territorial matrix reconstruction efforts focus on achieving natural fibril orientation, proteoglycan density, and mechanical strength. These properties are observed and monitored using the above mentioned analytical methods. By replicating the structure of natural cartilage as closely as possible, the bioengineered tissues are more likely to integrate with the native tissues and sustain loading.
August Wilhelm joined the conservative nationalist veterans group Der Stahlhelm (English: "The Steel helmet"). In the following years he had increasing contact with the NSDAP. He joined the Nazi Party on 1 April 1930, whereupon he received the low membership number 24, for symbolic reasons. In November 1931, he was accepted into the paramilitary Sturmabteilung (SA) with the rank of Standartenführer. His involvement with the NSDAP and his adoration of Adolf Hitler made August Wilhelm often the subject of mockery by the left-wing press (who gave him the nickname Braunhemdchen Auwi, or "Auwi the Little Brown Shirt"), politicians (French Ambassador André François-Poncet called him Hanswurst "Hans the Brown Sausage") and from the National Socialists themselves (Joseph Goebbels referred to him as a "good-natured but slightly gormless boy"). As a representative of the erstwhile Hohenzollern dynasty, August Wilhelm was deliberately used by the party to gain votes in elections: he was elected as its lead candidate for the Landtag of Prussia in April 1932, and retained his seat until the Landtag's dissolution in October 1933. At the same time, he was appointed an election speaker alongside Hitler, whom he accompanied on flights across Germany. Through his appearances at the party's mass rallies, he addressed himself to sections of the population that were lukewarm towards National Socialism and convinced them "that Hitler was not a threat, but a benefactor of the German people and the German Empire".
=== EC 2.9: selenium transferases === EC 2.9 includes enzymes that transfer selenium-containing groups. This category only contains two transferases, and thus is one of the smallest categories of transferase. Selenocysteine synthase, which was first added to the classification system in 1999, converts seryl-tRNA(Sec UCA) into selenocysteyl-tRNA(Sec UCA).
In molecular biology, immunophilins are a group of endogenous cytosolic peptidyl-prolyl isomerases (PPI), which catalyze the interconversion between the cis and trans isomers of peptide bonds containing the amino acid proline (Pro). They are chaperone molecules that generally assist in the proper folding of diverse "client" proteins. There are two families of immunophilins that are structurally unrelated, but have similar biochemical activity: cyclosporin-binding cyclophilins (CyPs) and FK506-binding proteins (FKBPs). In 2005, a group of dual-family immunophilins (DFI) has been discovered, mostly in unicellular organisms; these DFIs are natural chimera of CyP and FKBPs, fused in either order (CyP-FKBP or FKBP-CyP). Immunophilins are named as such because they were originally discovered in the context of immunosuppressive drugs; however both families of prolyl isomerases are ubiquitous across taxa and have diverse functions.
Sources: en.wikipedia.org
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.
The 2-aza-β-tyrosine subunit of kedarcidin chromophore is altogether unknown in any other natural product; this lack of precedence frustrates any attempt at a priori identification of the genes responsible for synthesizing this structure. However, six genes are conserved among the biosynthetic clusters of kedarcidin, C-1027, and maduropeptin—while these later two enediynes do not contain a 2-aza-β-tyrosine subunit, they do feature similar (L)-tyrosine-derived components, leading Shen et al. to propose a pathway for the synthesis of the corresponding kedarcidin subunit beginning with 2-aza-L-tyrosine. This α-amino acid is thus believed to be converted to the corresponding β-amino acid by KedY4, an aminomutase encoded in the ked cluster. The resulting product is believed to be loaded onto the peptidyl carrier protein KedY2 and subsequently chlorinated by KedY3, an flavin adenine dinucleotide-dependent halogenase.
In August, Jamie Brewer, Elle Chapman, Seth Gabel, Orlando Jones, Tig Notaro, Madelaine Petsch, Fedor Steer, and Zach Villa were confirmed as part of the cast. Murphy revealed that Paulson was set to play six to seven roles, while Peters was set to play five characters. Lange reprised all four of her characters from the first four seasons, along with a fifth undisclosed character, and confirmed having a musical number as Elsa Mars.
Sources: en.wikipedia.org
== Medical uses == ACAM2000 is indicated for active immunization against smallpox disease for individuals determined to be at high risk for smallpox infection. It is also indicated for the active prevention of mpox disease in individuals determined to be at high risk for mpox infection.
== Interactions == Catalase has been shown to interact with the ABL2 and Abl genes. Infection with the murine leukemia virus causes catalase activity to decline in the lungs, heart and kidneys of mice. Conversely, dietary fish oil increased catalase activity in the heart, and kidneys of mice.
Algae ( AL-jee, UK also AL-ghee; sing.: alga ) are any of a large and diverse group of photosynthetic organisms. It excludes the land plants (embryophytes). Such organisms range from microscopic unicellular microalgae (including cyanobacteria and phytoplankton) to seaweeds, multicellular macroalgae which may grow up to 50 metres (160 ft) in length. Most algae are aquatic (especially marine), and some form cohesive colonies. Freshwater algae include Charophyta such as the filamentous Spirogyra and the grasslike stoneworts. Most algae are plankton carried passively by water, although some macroalgae have holdfasts for anchorage. Algae are polyphyletic as they have multiple evolutionary origins. Although algae with two-membraned chloroplasts seem to form a paraphyletic group within the clade Archaeplastida, other algae with chloroplasts that have three or more membranes evolved from protists that acquired photosynthesis after engulfing archaeplastids. Chlorophytes, rhodophytes (red algae) and glaucophytes (grey algae) have primary chloroplasts directly derived from endosymbiont cyanobacteria, while diatoms, cryptomonads, euglenoids and phaeophyceae (brown algae) have secondary chloroplasts derived from indirectly endosymbiont red algae or green algae. Most algae are single-celled organisms without roots, leaves, or stems. Most are photoautotrophs and the main primary producers of aquatic ecosystems, although some are mixotrophs that derive metabolic energy both from internal photosynthesis and from foraging external nutrients.
== External links == Motilin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Nosek TM. "Section 6/6ch2/s6ch2_26". Essentials of Human Physiology. Archived from the original on 2016-03-24.
Sources: en.wikipedia.org
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.
The core four residues correspond to tuftsin, which occurs naturally as part of immunoglobulin G. The full seven-residue sequence, however, is not a known endogenous peptide. It is a laboratory-designed analogue intended to combine tuftsin-like activity with greater resistance to breakdown.
No single receptor has been confirmed as the primary target. Reports describe involvement of the GABAergic system, interference with enkephalin degradation, and shifts in neurotrophic factor expression. Because these observations come from different models and assays, they have not yet been integrated into one accepted mechanism.
Selank is a seven-amino-acid peptide built from the tuftsin sequence plus a Pro-Gly-Pro tail. It is produced by chemical synthesis rather than extracted from a natural source. The free peptide is usually supplied as a lyophilised powder or in an aqueous formulation.